News

MedCity News12h
New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others
In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...
STAT8d
Novavax wins narrowed approval for its Covid-19 shot after delay
Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli
Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...
Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.